Altered metabolic parameters in association with antipsychotic medication use in diabetes: A population based case-control study

D. J. Wake, P. Broughton, S. M. Perera, D. J. MacIntyre, G. P. Leese

Research output: Contribution to journalArticlepeer-review

Abstract

Aims This study assess differences in clinical variables in diabetes patients prescribed antipsychotic medication and determines relative schizophrenia prevalence in the diabetes population. Methods This population-based case-control study utilizing Scotland’s national diabetes registry (SCI-diabetes) and linked psychiatric hospital discharge data (SMR04) established diabetes phenotypes in a patient cohort prescribed long term antipsychotic medication (n = 2362) (cases). Cases were matched 1:10 to diabetes patients not prescribed antipsychotic medication (controls) for BMI, gender; diabetes type; birth year; diagnosis date; smoking status. Sub-groups with defined schizophrenia (n = 196) or bipolar disorder (n = 190) were further examined. Schizophrenia prevalence in the diabetes versus general population was compared. Results During follow up, antipsychotic prescription was associated with lower HbA1c (55.1 (95% CI 54.5–55.8) or 7.2 (95% CI 7.1–7.3)% vs 58.2 (58.0–58.4) mmol or 7.5 (95% CI 7.5–7.5)% p < 0.001) lower serum total cholesterol, 4.2 (4.1–4.2) vs 4.3 (4.2–4.3) mmol/l, p < 0.001, lower blood pressure (systolic 130 (130.17–131.29) vs 134 (134.3–134.7) mmHg, p < 0.001), higher prescription of oral hypoglycaemic medication (42% (40–45) vs 38% (37–39) p < 0.001), similar statin prescriptions (85% (81–89) vs 85% (84–86), p = 0.55), and lower retinopathy rates (28% (25.6–30.5) vs 32% (31.5–33.1), p < 0.001). HbA1c at diagnosis was similar (p = 0.27). Schizophrenia prevalence was higher in the diabetes versus general population with differences across age groups (Scottish population versus diabetic population rate of 522.2 (522.1–522.3) versus 717.4 (703.4–731.9) per 100,000). Conclusions We confirm higher diabetes rates in schizophrenia up to age 70, similar attendance rates and clinical measurements that are not worse in a large well-matched population-based Scottish sample prescribed antipsychotic medication versus matched general diabetes patients.
Original languageEnglish
Pages (from-to)214-220
Number of pages7
JournalPsychoneuroendocrinology
Volume66
Early online date23 Jan 2016
DOIs
Publication statusPublished - Apr 2016

Keywords

  • antipsychotics
  • Case-Control
  • Diabetes
  • Mental health
  • metabolic
  • Schizophrenia

Fingerprint

Dive into the research topics of 'Altered metabolic parameters in association with antipsychotic medication use in diabetes: A population based case-control study'. Together they form a unique fingerprint.

Cite this